image_alt_text
1

Fellowbook News

AIMBE Fellowbook collects news stories highlighting the members of the AIMBE College of Fellows. Read the latest stories, jump to the College Directory, or search below to find the newest research, awards, announcements and more for the leaders of the medical and biological engineering community.

 

 

Experts Study Marine Mammals To Learn About Human Hearing

Barbara Shinn-Cunningham | Via Carnegie Mellon University | June 30, 2022

Many hearing loss patients have the same complaint: They have trouble following conversations in a noisy space. Carnegie Mellon University’s Barbara Shinn-Cunningham has spent her career conducting research to better understand this problem and how it affects people at cocktail parties, coffee shops and grocery stores. Now, along with a team of researchers from six […]

Breast Cancer’s Spread Accelerates During Sleep

Sunitha Nagrath | Via Medpage Today | June 28, 2022

Breast cancer metastases spread far more efficiently during sleep, according to a Swiss study. While it has been assumed that circulating tumor cells (CTCs) are constantly shedding from growing tumors, or as a result of mechanical insults, there’s a “striking and unexpected pattern of CTC generation dynamics in both patients with breast cancer and mouse […]

Tissue model reveals key players in liver regeneration

Sangeeta Bhatia | Via MIT | June 27, 2022

By tracing the steps of liver regrowth, MIT engineers hope to harness the liver’s regenerative abilities to help treat chronic disease. The human liver has amazing regeneration capabilities: Even if up to 70 percent of it is removed, the remaining tissue can regrow a full-sized liver within months. Taking advantage of this regenerative capability could […]

Using DNA to better calculate a dog’s age

Trey Ideker | Via Veterinary Practice News | June 27, 2022

Where the long-accepted one-to-seven ratio came from is unknown, but a 2020 study determined the equation to be wildly inaccurate For decades, a dog’s age in human years has been determined by a general ratio of one dog year to seven human years, so a three-year-old dog would be the physical equivalent of a 21-year-old […]

Nanomaterials That Provide Imaging While Delivering Medication

Kytai Nguyen | Via University of Texas at Arlington | June 24, 2022

A University of Texas at Arlington bioengineer is leading a project that will develop biodegradable nanomaterials that will take pictures and deliver medicine to combat peripheral arterial disease (PAD). Kytai Nguyen, a UT Arlington bioengineering professor, is the principal investigator in the four-year, $2.1 million National Institutes of Health (NIH) grant. She’s collaborating with Jian […]

Lipid nanoparticles carry gene-editing cancer drugs past tumor defenses

Daniel Siegwart | Via UT Southwestern | June 23, 2022

As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break down the physical barriers around tumors to reach cancer cells. Once inside, the nanoparticles release their payload: a gene editing system […]

Self-plugging Microneedles Offer Potential to Improve Delivery of Drugs into the Eyeball

Ali Khademhosseini | Via Terasaki Institute | June 17, 2022

Published research on new eye treatment delivery shows improvement over hypodermic needles A collaborative team, including scientists from the Terasaki Institute for Biomedical Innovation (TIBI), has developed a novel, self-plugging microneedle for injecting therapeutics into the eyes, potentially solving one of the major challenges of treating eye diseases – accurate delivery of therapeutic drugs to […]

Robert Langer wins BBVA Foundation Frontiers of Knowledge Award

Robert Langer | Via MIT | June 17, 2022

Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles. Robert Langer, the David H. Koch (1962) Institute Professor at MIT, received yesterday the 2022 BBVA Foundation Frontiers of Knowledge Award in Biology and Biomedicine in recognition of his contributions to messenger (mRNA) therapeutics and delivery technology, which enabled the rapid development of […]

Dr. Cato T. Laurencin Elected to the European Academy of Sciences

Cato Laurencin | Via University of Connecticut | June 16, 2022

The prestigious European Academy of Sciences has recognized UConn’s Dr. Cato T. Laurencin for his visionary and pioneering work in the field of regenerative engineering In recognition of his pioneering work in the field of regenerative engineering, UConn professor Dr. Cato T. Laurencin has been elected to the prestigious European Academy of Sciences (EURASC). “It’s […]

Understanding Poor Vaccine Responses in Individuals With Weakened Immune Systems

Rong Fan | Via Yale School of Medicine | June 16, 2022

When the COVID-19 vaccine first became available, people eagerly signed up for coveted slots to boost their antibodies against the virus that shut down much of the world. But not everyone who rolled up their sleeve received equal protection from illness. A significant proportion of the population has weakened immune systems, including cancer patients, those […]

Lydia Contreras Named New Vice Provost for Faculty Diversity

Lydia Contreras | Via The University of Texas at Austin | June 15, 2022

The University of Texas at Austin has named Lydia Contreras as its new vice provost for faculty diversity, equity and inclusivity, effective immediately. Contreras, who currently holds the Jim and Barbara Miller Endowed Faculty Fellowship in Chemical Engineering, has served for the past two years as the managing director of diversity in the Office of […]

$2.38M to test nano-engineered brain cancer treatment in mice

Joerg Lahann | Via University of Michigan | June 15, 2022

A protein that crosses the blood-brain barrier carries a drug that kills tumor cells and another that activates the immune system A new nanomedicine that crosses the blood-brain barrier, engages the immune system and kills cancer cells may offer hope for treating the most aggressive form of brain cancer, glioblastoma. With $2.38 million in funding […]

Nanoparticle sensor can distinguish between viral and bacterial pneumonia

Sangeeta Bhatia | Via MIT | June 13, 2022

Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective. Many different types of bacteria and viruses can cause pneumonia, but there is no easy way to determine which microbe is causing a particular patient’s illness. This uncertainty makes it harder for doctors to choose effective treatments because the antibiotics […]

U.S. Sen. Baldwin: Visits Milwaukee to highlight investments she brought home for the community

Jeffrey Toth | Via WIS Politics | June 8, 2022

This week, U.S. Senator Tammy Baldwin visited Milwaukee to highlight federal investments she secured for community organizations through legislation signed into law by President Biden earlier this year. At Green Bay Avenue Elementary, Senator Baldwin joined Milwaukee Public Schools (MPS) Superintendent Dr. Keith Posley, Marquette University President Dr. Michael Lovell, and educators from the MPS […]

Investigators unlocking mysteries of cell-based therapies

Adam Feinberg | Via Ophthalmology Times | June 8, 2022

For some time, cell-based therapies have been viewed as an alternative treatment option for patients with a range of diseases caused by tissue failure, including corneal blindness. These therapies have shown great promise in theory, but when put into practice have offered limited clinical success in many applications due to low cell viability after injection, […]

Surprise! Noradrenaline Helps the Brain Learn from Unexpected Events

Mriganka Sur | Via Genetic Engineering & Biotechnology News | June 2, 2022

Noradrenaline is a neuromodulator that has been linked to arousal and boosting alertness, but can lead to anxiety in large amounts. Unlike neurotransmitters, which enable cell-to-cell communication, neuromodulators are released over large swathes of the brain, allowing them to exert more general effects. Previous studies of the locus coeruleus (LC), the primary source of noradrenaline […]

Engineers develop nanoparticles that cross the blood-brain barrier

Paula Hammond | Via MIT | June 1, 2022

There are currently few good treatment options for glioblastoma, an aggressive type of brain cancer with a high fatality rate. One reason that the disease is so difficult to treat is that most chemotherapy drugs can’t penetrate the blood vessels that surround the brain. A team of MIT researchers is now developing drug-carrying nanoparticles that […]

Engineers develop nanoparticles that cross the blood-brain barrier

Roger Kamm | Via MIT | June 1, 2022

There are currently few good treatment options for glioblastoma, an aggressive type of brain cancer with a high fatality rate. One reason that the disease is so difficult to treat is that most chemotherapy drugs can’t penetrate the blood vessels that surround the brain. A team of MIT researchers is now developing drug-carrying nanoparticles that […]

No more flu for you? Discovery blocks influenza virus’ replication in cells

Jiayu Liao | Via University of California, Riverside | May 31, 2022

SUMOylation inhibitor could lead to highly effective ways to treat the flu and other respiratory viruses It happens every year, especially in winter. A virus saunters into your wide-open respiratory tract, worms its way into lung cells, and, next thing you know, you’re lying in bed with a fever, aches, and chills—classic symptoms of influenza, […]

AI Used for Analysis of NBA Players’ Movement May Help Develop Cancer Treatments

Dong Xu | Via Pharmacy Times | May 25, 2022

Pharmacy Times interviewed Dong Xu, PhD, MS, curators’ distinguished professor, Department of Electrical Engineering and Computer Science, University of Missouri College of Engineering, on research assessing the application of a form of artificial intelligence (AI) to help scientists develop new drug therapies for medical treatments targeting cancers and other diseases. Alana Hippensteele: Hi, I’m Alana […]